These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 7931070)
1. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. Chang CH; Fontes JD; Peterlin M; Flavell RA J Exp Med; 1994 Oct; 180(4):1367-74. PubMed ID: 7931070 [TBL] [Abstract][Full Text] [Related]
2. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Butticè G; Miller J; Wang L; Smith BD Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692 [TBL] [Abstract][Full Text] [Related]
4. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643 [TBL] [Abstract][Full Text] [Related]
5. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines. Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572 [TBL] [Abstract][Full Text] [Related]
6. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes. Lee YJ; Benveniste EN J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739 [TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426 [TBL] [Abstract][Full Text] [Related]
8. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988 [TBL] [Abstract][Full Text] [Related]
9. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W; Tang LP; Dong Y; Benveniste EN J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712 [TBL] [Abstract][Full Text] [Related]
10. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells. Rahat MA; Chernichovski I; Lahat N Int Immunol; 2001 Nov; 13(11):1423-32. PubMed ID: 11675374 [TBL] [Abstract][Full Text] [Related]
11. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283 [TBL] [Abstract][Full Text] [Related]
12. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha. Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975 [TBL] [Abstract][Full Text] [Related]
13. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression. Zika E; Fauquier L; Vandel L; Ting JP Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053 [TBL] [Abstract][Full Text] [Related]
14. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. Chang CH; Flavell RA J Exp Med; 1995 Feb; 181(2):765-7. PubMed ID: 7836928 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the in vivo role of class II transactivator in basal and IFN-gamma induced class II expression in mouse tissue. Ramassar V; Goes N; Hobart M; Halloran PF Transplantation; 1996 Dec; 62(12):1901-7. PubMed ID: 8990384 [TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294 [TBL] [Abstract][Full Text] [Related]
17. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes. Lu Y; Tschickardt ME; Schmidt BJ; Blanck G Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472 [TBL] [Abstract][Full Text] [Related]
18. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2. Xi H; Goodwin B; Shepherd AT; Blanck G Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288 [TBL] [Abstract][Full Text] [Related]
19. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Piskurich JF; Linhoff MW; Wang Y; Ting JP Mol Cell Biol; 1999 Jan; 19(1):431-40. PubMed ID: 9858567 [TBL] [Abstract][Full Text] [Related]
20. Kinase inhibitors abrogate IFN-gamma-induced class II transactivator and class II MHC gene expression in astroglioma cell lines. Van Wagoner NJ; O'Keefe GM; Benveniste EN J Neuroimmunol; 1998 May; 85(2):174-85. PubMed ID: 9630166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]